The DLM requires these reagents to perform testing for the NIH Clinical Center patients for Prothrombin Time Assay, activated Prothrombin Time Assay, Fibrinogen Assay, Thrombin Time Assay, D-Dimer Assay, Mixing Studies Assays, Kaolin Clotting Time Assay, Factor Assays, Antithrombin III Assay, Alpha 2 Antiplasmin Assay, Protein C Assay, Protein S Assay, Lupus Anticoagulant Assays, Anti Xa Assays, Plasminogen Assay, Plasminogen Activator Inhibitor -1 Assay, Reptilase Assay, von Willebrand Antigen Assay and monitor therapeutic for Direct Thrombin inhibitor.
The testing supports the analyzing of all CC coagulation testing samples obtained for clinical diagnosis.
Please see attached for items request
All quotations shall be received no later than 12:00PM, ET on December 23rd, 2015. Email submissions of quotations shall be submitted to [email protected], contract specialist. Please submit all questions by January 5th, 2016, 9:00 a.m. Eastern Standard Time. Responses to questions will be posted to this notice by the Close of Business December 30th, 2015
PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: see above. Certifications Commercial Items FAR 52.212-3 Offeror Representations and Certifications-Commercial Items. (APR 2012). The clause at FAR 52.212-4, Contract Terms and Conditions, The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.203-13, FAR 52.209-6, FAR 52.211-6, FAR 52.217-5, FAR 52.217-8, FAR 52.217-9, FAR 52.222-3, FAR 52.222-19, FAR 52.222-21, FAR 52.222-56, FAR 52.222-35, FAR 52.222-36, FAR 52.222-37, FAR 52.223-15, FAR 52.223-18, FAR 52.225-1 and FAR 52.232-33, FAR 52.246-16. Clauses and provisions are incorporated by reference and apply to this acquisition.